NDC11 62332034630
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 62332-0346-30 | 62332-0346 |
| 62332-346-30 | 62332-346 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RIVAROXABAN | RIVAROXABAN | Alembic Pharmaceuticals Inc. | e62f23c6-89f2-4179-95dc-5732401b3f93 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 62332-346-30 62332-346 62332034630 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.